Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan;40(1):73-78.
doi: 10.1007/s00381-023-06105-w. Epub 2023 Sep 2.

Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review

Kelsey D Cobourn  1 , Kelsi M Chesney  1 , Kyle Mueller  1 , Islam Fayed  1 , Deki Tsering  1 , Robert F Keating  2
Affiliations
Review

Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review

Kelsey D Cobourn et al. Childs Nerv Syst. 2024 Jan.

Abstract

Purpose: Subependymal giant cell astrocytoma (SEGA) is a WHO grade I pediatric glioma arising in 5-15% of patients with tuberous sclerosis (TSC). Rare cases of isolated SEGA without TSC have been described. The etiology, genetic mechanisms, natural history, and response to treatment of these lesions are currently unknown. We describe two such cases of isolated SEGA with follow-up.

Methods: Retrospective review was performed at a single institution to describe the clinical course of pathology-confirmed SEGA in patients with germline testing negative for TSC mutations.

Results: Two cases of isolated SEGA were identified. Genetic analysis of the tumor specimen was available for one, which revealed an 18 base pair deletion in TSC1. Both cases were managed with surgical resection, one with preoperative embolization. In spite of a gross total resection, one patient experienced recurrence after three years. Treatment with an mTOR inhibitor led to a significant interval reduction of the mass on follow-up MRI. The patient tolerated the medication well for 6 years and is now off of treatment for 2 years with a stable lesion.

Conclusion: Cases of SEGA outside of the context of TSC are exceedingly rare, with only 48 cases previously described. The genetic mechanisms and treatment response of these lesions are poorly understood. To date, these lesions appear to respond well to mTOR inhibitors and may behave similarly to SEGAs associated with TSC. However, given that experience is extremely limited, these cases should be followed long term to better understand their natural history and treatment response.

Keywords: Genetic mosaicism; Germline testing; Subependymal giant cell astrocytoma (SEGA); Tuberous sclerosis complex (TSC); mTOR inhibitors.

PubMed Disclaimer

References

    1. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–20. https://doi.org/10.1007/s00401-016-1545-1 - DOI - PubMed
    1. Adriaensen ME, Schaefer-Prokop CM, Stijnen T, Duyndam DA, Zonnenberg BA, Prokop M (2009) Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol 16(6):691–6. https://doi.org/10.1111/j.1468-1331.2009.02567.x - DOI - PubMed
    1. Chan DL, Calder T, Lawson JA, Mowat D, Kennedy SE (2018) The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review. Rev Neurosci 29(3):295–301. https://doi.org/10.1515/revneuro-2017-0027 - DOI - PubMed
    1. Shepherd CW, Scheithauer BW, Gomez MR, Altermatt HJ, Katzmann JA (1991) Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study. Neurosurgery 28(6):864–8 - DOI - PubMed
    1. Magri L, Galli R (2013) Mtor signaling in neural stem cells: from basic biology to disease. Cell Mol Life Sci 70(16):2887–98. https://doi.org/10.1007/s00018-012-1196-x - DOI - PubMed

MeSH terms

LinkOut - more resources